Prevention Study in Adult Patients Suffering From Migraine Headaches
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
Purpose of the study is to evaluate dose response relationship, efficacy, safety and
tolerability of target doses of GSK1838262 compared to placebo in the prophylactic treatment
of migraine headache. Once subjects complete the baseline and meet the randomization
criteria, they will complete a 5-wk flexible titration period and then enter the 12 week
maintenance period.